Mesoblast (NASDAQ:MESO) Downgraded to "Hold" Rating by …

Dec 23, 2024 · A number of other analysts also recently issued reports on MESO. Maxim Group raised Mesoblast from a "hold" rating to a "buy" rating and set a $12.00 target price on the stock in a research report on Tuesday, September 24th. StockNews.com cut Mesoblast from a "hold" …

$12.00
OFF

Mesoblast (NASDAQ:MESO) Downgraded To "Hold" Rating By …

2 weeks from now

marketbeat.com

$17.02
OFF

Mesoblast (NASDAQ:MESO) Cut To Hold At Jefferies Financial Group

2 weeks from now

Dec 25, 2024 · Shares of NASDAQ:MESO opened at $17.02 on Monday. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.18 and a quick ratio of 1.18. Mesoblast has a …

etfdailynews.com

$12.00
OFF

Mesoblast (NASDAQ:MESO) Shares Gap Down - Here's What …

2 weeks from now

Jan 3, 2025 · Maxim Group upgraded Mesoblast from a "hold" rating to a "buy" rating and set a $12.00 target price on the stock in a research report on Tuesday, September 24th. Finally, …

marketbeat.com

$2.30
OFF

Mesoblast Downgraded To Hold From Buy At Jefferies - Nasdaq

2 weeks from now

Dec 23, 2024 · Jefferies downgraded Mesoblast (MESO) to Hold from Buy with a price target of A$2.30, up from A$1.10. The firm updated the company’s for the FDA’ss recent approval of …

nasdaq.com

$11.00
OFF

Mesoblast (NASDAQ:MESO) Shares Gap Down – Time To Sell?

2 weeks from now

Jan 5, 2025 · MESO has been the subject of several research reports. Piper Sandler upped their target price on Mesoblast from $11.00 to $15.00 and gave the stock an “overweight” rating in a …

tickerreport.com

4%
OFF

Mesoblast (NASDAQ:MESO) Shares Down 3.4% - MarketBeat

2 weeks from now

Jan 7, 2025 · Jefferies Financial Group lowered Mesoblast from a "buy" rating to a "hold" rating in a research note on Monday, December 23rd. Piper Sandler upped their price target on shares …

marketbeat.com

7%
OFF

Mesoblast (NASDAQ:MESO) Stock Price Down 5.7% - MarketBeat

2 weeks from now

Dec 27, 2024 · Jefferies Financial Group lowered Mesoblast from a "buy" rating to a "hold" rating in a research note on Monday. Finally, Maxim Group upgraded Mesoblast from a "hold" rating …

marketbeat.com

$12.00
OFF

Mesoblast (NASDAQ:MESO) Shares Gap Down - Time To Sell?

2 weeks from now

1 day ago · MESO has been the topic of a number of recent research reports. Maxim Group raised Mesoblast from a "hold" rating to a "buy" rating and set a $12.00 target price on the …

marketbeat.com

6%
OFF

Mesoblast (NASDAQ:MESO) Shares Up 13.6% - Time To Buy?

2 weeks from now

Dec 14, 2024 · Cantor Fitzgerald reissued an "overweight" rating on shares of Mesoblast in a research report on Thursday, August 29th. StockNews.com cut shares of Mesoblast from a …

marketbeat.com

FAQs about Mesoblast (NASDAQ:MESO) Downgraded to "Hold" Rating by … Coupon?

Is Mesoblast (meso) a good stock to buy?

Mesoblast (NASDAQ:MESO – Get Free Report) was downgraded by investment analysts at Jefferies Financial Group from a “buy” rating to a “hold” rating in a research report issued on Monday, MarketBeat reports. MESO has been the topic of several other reports. ...

Did Jefferies downgrade the outlook for Mesoblast limited - depositary receipt (meso)?

This story originally appeared on Fintel. Fintel reports that on December 23, 2024, Jefferies downgraded their outlook for Mesoblast Limited - Depositary Receipt () (NasdaqGS:MESO) from Buy to Hold. ...

What happened to Mesoblast's share price?

Mesoblast's share price declined 84 per cent from $4.54 to $2.46 between December 14 and the last Thursday. ...

How much does Mesoblast (meso) cost?

Shares of NASDAQ:MESO opened at $17.02 on Monday. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.18 and a quick ratio of 1.18. Mesoblast has a 12 month low of $1.61 and a 12 month high of $19.15. The stock’s 50 day moving average price is $10.77 and its 200 day moving average price is $8.44. ...

How do I receive news & ratings for Mesoblast?

Receive News & Ratings for Mesoblast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast and related companies with MarketBeat.com's FREE daily email newsletter. ...

What is Piper Sandler's target price on Mesoblast?

Piper Sandler upped their target price on Mesoblast from $11.00 to $15.00 and gave the stock an “overweight” rating in a research report on Thursday, December 19th. Maxim Group upgraded Mesoblast from a “hold” rating to a “buy” rating and set a $12.00 price objective on the stock in a report on Tuesday, September 24th. ...